2004
DOI: 10.1038/sj.leu.2403605
|View full text |Cite
|
Sign up to set email alerts
|

Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies

Abstract: Chromosomal translocations that target HMGA2 at chromosome band 12q14 are seen in a variety of malignancies, notably lipoma, pleomorphic salivary adenoma and uterine leiomyoma. Although some HMGA2 fusion genes have been reported, several lines of evidence suggest that the critical pathogenic event is the expression of truncated HMGA2 isoforms. We report here the involvement of HMGA2 in six patients with myeloid neoplasia, dysplastic features and translocations or an inversion involving chromosome bands 12q13-1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
60
0
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(66 citation statements)
references
References 37 publications
2
60
0
2
Order By: Relevance
“…In these studies, the virus was relatively often inserted into the HMGA2 locus, leading to removal of binding sites for let -7 miRNA and clonal outgrowth of hematopoietic cells, which brought a long -term effect including continuous independence of blood transfusion in severe thalassemia 70) . Overexpression and/or truncation of HMGA2 has also been found in patients with PNH and MDS, in which bone marrow failure rather than proliferative hematopoiesis is a common feature 26,68,72) . Bone marrow failure in these disorders is partly due to immunologic HSC injury by autoreactive cytotoxic T lymphocytes (CTLs) that produce tumor necrosis factor (TNF) -α and interferon (IFN) -γ 73 -75) .…”
Section: Discussionmentioning
confidence: 99%
“…In these studies, the virus was relatively often inserted into the HMGA2 locus, leading to removal of binding sites for let -7 miRNA and clonal outgrowth of hematopoietic cells, which brought a long -term effect including continuous independence of blood transfusion in severe thalassemia 70) . Overexpression and/or truncation of HMGA2 has also been found in patients with PNH and MDS, in which bone marrow failure rather than proliferative hematopoiesis is a common feature 26,68,72) . Bone marrow failure in these disorders is partly due to immunologic HSC injury by autoreactive cytotoxic T lymphocytes (CTLs) that produce tumor necrosis factor (TNF) -α and interferon (IFN) -γ 73 -75) .…”
Section: Discussionmentioning
confidence: 99%
“…Co-amplification and overexpression of HMGA2 and CDK4 genes at chromosomal region 12q14 occurs in some human cancers such as breast cancers and glioblastomas, and may cooperate to transform cells. HMGA2 is also targeted in cases of myelodysplasia (51). Myelodysplasia is a pathological syndrome that often precedes acute leukemia.…”
Section: Cooperation In Cyclementioning
confidence: 99%
“…In some of them, the partner gene in translocation (or inversion) was identified, although 3 0 RACE-PCR analysis excluded the possibility of a fusion transcript. 6,7 In some of them, aberrant truncated forms of HMGA2 transcripts were described as containing exons 1-3 and a sequence from intron 3 or intron 2, 7 leading to truncation of the acidic carboxyl domain of the protein. 6,7 HMGA2 activation has been reported in myelodysplasia 7 and myelofibrosis with myeloid metaplasia, 6 but never in PV.…”
mentioning
confidence: 99%
“…6,7 In some of them, aberrant truncated forms of HMGA2 transcripts were described as containing exons 1-3 and a sequence from intron 3 or intron 2, 7 leading to truncation of the acidic carboxyl domain of the protein. 6,7 HMGA2 activation has been reported in myelodysplasia 7 and myelofibrosis with myeloid metaplasia, 6 but never in PV. Reverse transcription (RT)-PCR and 3 0 RACE-PCR excluded the formation of a 5 0 HMGA2/3 0 TNIK chimeric transcript and, moreover, no difference in the transcriptional pattern of the TNIK gene was observed among PV patients (Figure 1g).…”
mentioning
confidence: 99%